Skip to main content
OpenTrials
Completed

NCT Number: NCT01913184

Lung Bioavailability With Continuous or Discontinuous Nebulization

To compare the continuous and sicontinuous delivery of drug with AKITA.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Subjects

Age range

18 year–50 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Cliniques universitaires Saint-Luc

Brussels, 1200, Belgium

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • no lung disease
  • no allergy

Exclusion criteria

  • smoker

Treatment and study plan

AKITA

Device

Primary outcomes

  1. Lung bioavailability by urinary monitoring

    Time frame: 24h after the nebulization

Secondary outcomes

  1. Duration of the nebulization

    Time frame: After the nebulization

Sponsors and collaborators

Lead sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Other

Registry information

Official study title

EFFECT OF DRUG TARGETING NEBULIZATION ON LUNG DELIVERY

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Jul 31, 2013
Registry last updated
Jul 31, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.